Abstract
Objective: This study evaluated whether sarcopenic obesity is closely associated with muscle quality using abdominal computed tomography.Methods: This cross‐sectional study included 13,612 participants who underwent abdominal computed tomography. The cross‐sectional area of the skeletal muscle was measured at the L3 level (total abdominal muscle area [TAMA]) and segmented into normal attenuation muscle area (NAMA, +30 to +150 Hounsfield units), low attenuation muscle area (−29 to +29 Hounsfield units), and intramuscular adipose tissue (−190 to −30 Hounsfield units). The NAMA/TAMA index was calculated by dividing NAMA by TAMA and multiplying by 100, and the lowest quartile of NAMA/TAMA index was defined as myosteatosis (p < 0.001) than the control group without sarcopenia or obesity. Compared with the control group, the odds ratio (95% CI) for having myosteatosis was 3.70 (2.87–4.76) for participants with sarcopenic obesity after adjusting for age, sex, smoking, drinking, exercise, hypertension, diabetes, low‐density lipoprotein cholesterol, and high‐sensitivity C‐reactive protein.Conclusions: Sarcopenic obesity is significantly associated with myosteatosis, which is representative of poor muscle quality.
Funding Information
  • National Research Foundation of Korea (2020R1A2C1101977, 2021R1I1A3051083)

This publication has 42 references indexed in Scilit: